+44 207 394 30 90 (London)
Production of medicines in the form of sachets and high-tech biosimilars
Operator/initiator: JSC Nobel AFF
Stage: Development of design estimates and feasibility studies
Dates: 2022–2025
Investments: $55 mil
This company will promote the development of domestic production of original medicines and medical devices, increase the export potential of domestic pharmaceutical products, as well as increase scientific and human potential.
Creation of a biopharmaceutical complex for the development and production of modern medicines
Operator/initiator: LLP Research and Production Complex Bio-Eurasia
Location: Almaty
Investments: $63,978 mil
Within the framework of the project, it is planned to build a biopharmaceutical complex for the development and production of the following modern medicines: immunosuppressants, immunomodulators, antiviral, anticancer, anti-inflammatory, hormonal, antianemic preparations, blood substitutes, antihemophilic, anticholinergic medicines, anesthetics, antioxidants, cardiovascular and phlebological medicines.
Production of biotechnological products
Operator/initiator: Ministry of Health
Location: Almaty
Stage: Preparation of documentation
Dates: 2022–2025
Investments: $57.89 mil
Vaccine production
Operator/initiator: Ministry of Health of the Republic of Kazakhstan
Location: Almaty
Stage: Preparation of documentation
Dates: 2022–2023
Investments: $36.61 mil
Production of nonwoven fabric
Operator/initiator: LLP Merusar and K
Location: Pavlodar
Investments: $43,591 mil
The project involves the construction of a plant for the production of nonwoven fabric with a capacity of 10,000 tonnes annually. Nonwoven materials are widely used for the production of personal protective equipment, disposable medical masks, gowns, drapes, сoveralls, etc. The production will be localised in the free economic zone in Pavlodar.
Construction of a plant for the dialysers production
Operator/initiator: Ministry of Health of the Republic of Kazakhstan
Location: Aktobe region
Stage: Difficulties with project financing
Date: The commissioning was previously scheduled for 2021, now the launch has been postponed to 2024
Investments: $7.74 mil
It is expected that the production capacity will be 1 mil dialysers per year. It is noted that this project has no analogues in Kazakhstan and the CIS. German technologies will be used at the plant.
